Podcast hosts Balaji Narasimhan, Kathleen Ross, and Mike Roof briefly discuss the work at the Nanovaccine Institute and the topics to be covered by the Nanovax Podcast.

Balaji Narasimhan, Anson Marston Distinguished Professor and Vlasta Klima Balloun Faculty Chair, Department of Chemical and Biological Engineering, Iowa State University; Director, Nanovaccine Institute

Kathleen Ross, Core Facility Manager, Research and Development Engineer III, Nanovaccine Institute

Mike Roof, Chief Technology Officer, Vaccines, Diagnostics, and Immunotherapeutics bioscience platform, Office of the Vice President for Research, Iowa State University

The Nanovaccine Institute was founded at Iowa State University building upon core partnerships with the University of Iowa and the University of Nebraska Medical Center. Our purpose is to use nano-based technologies to tackle emergent diseases that have a devastating impact on human and animal health.

Iowa State University does not discriminate on the basis of race, color, age, ethnicity, religion, national origin, pregnancy, sexual orientation, gender identity, genetic information, sex, marital status, disability, or status as a U.S. Veteran. Inquiries regarding non-discrimination policies may be directed to Office of Equal Opportunity, 3410 Beardshear Hall, 515 Morrill Road, Ames, Iowa 50011, Tel. 515-294-7612, Hotline 515-294-1222, email eooffice@iastate.edu.